| 1.6 |
4.8 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.4 |
4.2 |
GO:0035621 |
ER to Golgi ceramide transport(GO:0035621) |
| 1.4 |
5.6 |
GO:0033869 |
coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
| 1.3 |
3.9 |
GO:0061181 |
regulation of chondrocyte development(GO:0061181) |
| 1.1 |
3.4 |
GO:0006507 |
GPI anchor release(GO:0006507) |
| 1.1 |
4.5 |
GO:1903760 |
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
| 1.1 |
3.3 |
GO:0010133 |
proline catabolic process to glutamate(GO:0010133) |
| 1.1 |
3.3 |
GO:0036228 |
protein targeting to nuclear inner membrane(GO:0036228) |
| 1.0 |
4.1 |
GO:1904412 |
regulation of cardiac ventricle development(GO:1904412) |
| 1.0 |
3.0 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 1.0 |
6.0 |
GO:0006663 |
platelet activating factor biosynthetic process(GO:0006663) |
| 1.0 |
3.9 |
GO:0003165 |
Purkinje myocyte development(GO:0003165) |
| 0.9 |
3.7 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.9 |
2.8 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.9 |
2.7 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.8 |
3.2 |
GO:0015744 |
succinate transport(GO:0015744) |
| 0.8 |
2.4 |
GO:0007529 |
establishment of synaptic specificity at neuromuscular junction(GO:0007529) |
| 0.8 |
4.0 |
GO:0033140 |
negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.8 |
4.0 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.8 |
3.8 |
GO:0009414 |
response to water deprivation(GO:0009414) |
| 0.7 |
2.2 |
GO:0045796 |
negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
| 0.7 |
2.9 |
GO:0099527 |
postsynapse to nucleus signaling pathway(GO:0099527) |
| 0.7 |
3.6 |
GO:0002484 |
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
| 0.7 |
0.7 |
GO:0071462 |
cellular response to water stimulus(GO:0071462) |
| 0.7 |
4.8 |
GO:0030950 |
establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.7 |
3.4 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.7 |
3.4 |
GO:0032902 |
nerve growth factor production(GO:0032902) |
| 0.7 |
0.7 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.7 |
6.5 |
GO:0015691 |
cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
| 0.7 |
3.9 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.6 |
2.6 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.6 |
0.6 |
GO:0098705 |
copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
| 0.6 |
1.9 |
GO:0002194 |
hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
| 0.6 |
1.9 |
GO:0061763 |
multivesicular body-lysosome fusion(GO:0061763) |
| 0.6 |
1.9 |
GO:0060010 |
Sertoli cell fate commitment(GO:0060010) |
| 0.6 |
1.2 |
GO:0048294 |
negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.6 |
3.7 |
GO:0044375 |
regulation of peroxisome size(GO:0044375) |
| 0.6 |
1.8 |
GO:0090341 |
negative regulation of secretion of lysosomal enzymes(GO:0090341) |
| 0.6 |
0.6 |
GO:0060741 |
prostate gland stromal morphogenesis(GO:0060741) |
| 0.6 |
2.4 |
GO:0097498 |
endothelial tube lumen extension(GO:0097498) |
| 0.6 |
6.0 |
GO:0046449 |
creatinine metabolic process(GO:0046449) |
| 0.6 |
1.8 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.6 |
6.5 |
GO:0032488 |
Cdc42 protein signal transduction(GO:0032488) |
| 0.6 |
0.6 |
GO:1902022 |
L-lysine transport(GO:1902022) |
| 0.6 |
0.6 |
GO:0060701 |
negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
| 0.6 |
2.9 |
GO:0003164 |
His-Purkinje system development(GO:0003164) bundle of His development(GO:0003166) |
| 0.6 |
2.3 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.6 |
10.9 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.6 |
1.7 |
GO:0061144 |
alveolar secondary septum development(GO:0061144) |
| 0.6 |
3.4 |
GO:0060431 |
primary lung bud formation(GO:0060431) |
| 0.6 |
2.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.6 |
1.7 |
GO:1904760 |
myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
| 0.6 |
1.7 |
GO:0061193 |
taste bud development(GO:0061193) |
| 0.5 |
2.2 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.5 |
1.6 |
GO:0060488 |
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
| 0.5 |
3.8 |
GO:0090298 |
negative regulation of mitochondrial DNA replication(GO:0090298) |
| 0.5 |
0.5 |
GO:0031204 |
posttranslational protein targeting to membrane, translocation(GO:0031204) |
| 0.5 |
4.3 |
GO:1990504 |
dense core granule exocytosis(GO:1990504) |
| 0.5 |
1.6 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 |
2.1 |
GO:0046294 |
formaldehyde catabolic process(GO:0046294) |
| 0.5 |
2.1 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.5 |
4.2 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.5 |
3.6 |
GO:2000124 |
regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.5 |
2.6 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.5 |
3.6 |
GO:0070055 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.5 |
0.5 |
GO:1902162 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 0.5 |
3.0 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.5 |
1.5 |
GO:0035973 |
aggrephagy(GO:0035973) |
| 0.5 |
0.5 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.5 |
1.0 |
GO:0070178 |
D-serine metabolic process(GO:0070178) |
| 0.5 |
1.0 |
GO:2000017 |
positive regulation of determination of dorsal identity(GO:2000017) |
| 0.5 |
2.0 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.5 |
1.5 |
GO:1905223 |
epicardium morphogenesis(GO:1905223) |
| 0.5 |
1.5 |
GO:0019448 |
cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
| 0.5 |
1.9 |
GO:2000384 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.5 |
1.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.5 |
1.4 |
GO:1903722 |
regulation of centriole elongation(GO:1903722) |
| 0.5 |
1.4 |
GO:0071680 |
response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.5 |
1.4 |
GO:0035880 |
embryonic nail plate morphogenesis(GO:0035880) |
| 0.5 |
2.8 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.5 |
0.5 |
GO:1990535 |
neuron projection maintenance(GO:1990535) |
| 0.5 |
1.9 |
GO:0060971 |
embryonic heart tube left/right pattern formation(GO:0060971) |
| 0.5 |
1.9 |
GO:0060128 |
corticotropin hormone secreting cell differentiation(GO:0060128) |
| 0.5 |
1.4 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.5 |
1.4 |
GO:0016256 |
N-glycan processing to lysosome(GO:0016256) |
| 0.5 |
2.8 |
GO:0051790 |
short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.5 |
1.8 |
GO:0034653 |
diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
| 0.5 |
0.9 |
GO:0071211 |
protein targeting to vacuole involved in autophagy(GO:0071211) |
| 0.5 |
2.3 |
GO:1903553 |
positive regulation of extracellular exosome assembly(GO:1903553) |
| 0.5 |
1.8 |
GO:0034757 |
negative regulation of iron ion transport(GO:0034757) negative regulation of iron ion transmembrane transport(GO:0034760) |
| 0.4 |
1.8 |
GO:0070671 |
response to interleukin-12(GO:0070671) |
| 0.4 |
1.8 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.4 |
1.3 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 0.4 |
1.3 |
GO:0031591 |
wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
| 0.4 |
0.4 |
GO:0002489 |
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
| 0.4 |
2.2 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.4 |
1.8 |
GO:1903422 |
negative regulation of synaptic vesicle recycling(GO:1903422) |
| 0.4 |
1.3 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
| 0.4 |
1.3 |
GO:0072434 |
signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.4 |
1.7 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 0.4 |
1.7 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 0.4 |
2.1 |
GO:1904398 |
positive regulation of neuromuscular junction development(GO:1904398) |
| 0.4 |
0.9 |
GO:0090365 |
regulation of mRNA modification(GO:0090365) |
| 0.4 |
0.4 |
GO:0010668 |
ectodermal cell differentiation(GO:0010668) |
| 0.4 |
2.1 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.4 |
1.3 |
GO:0000066 |
mitochondrial ornithine transport(GO:0000066) |
| 0.4 |
0.4 |
GO:0031064 |
negative regulation of histone deacetylation(GO:0031064) |
| 0.4 |
1.3 |
GO:0060365 |
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
| 0.4 |
1.3 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.4 |
2.5 |
GO:0075044 |
autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
| 0.4 |
0.8 |
GO:2000111 |
positive regulation of macrophage apoptotic process(GO:2000111) |
| 0.4 |
1.2 |
GO:2000158 |
positive regulation of ubiquitin-specific protease activity(GO:2000158) |
| 0.4 |
1.2 |
GO:0006208 |
pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
| 0.4 |
1.6 |
GO:1903031 |
regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.4 |
2.0 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.4 |
2.8 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.4 |
1.6 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.4 |
1.6 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.4 |
1.2 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.4 |
4.4 |
GO:0006465 |
signal peptide processing(GO:0006465) |
| 0.4 |
1.2 |
GO:0042726 |
flavin-containing compound metabolic process(GO:0042726) |
| 0.4 |
2.0 |
GO:1904352 |
positive regulation of protein catabolic process in the vacuole(GO:1904352) |
| 0.4 |
1.2 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.4 |
0.8 |
GO:0048105 |
establishment of body hair or bristle planar orientation(GO:0048104) establishment of body hair planar orientation(GO:0048105) |
| 0.4 |
1.6 |
GO:1902530 |
regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 0.4 |
1.2 |
GO:0010730 |
negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.4 |
1.5 |
GO:0002023 |
reduction of food intake in response to dietary excess(GO:0002023) |
| 0.4 |
0.4 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.4 |
1.1 |
GO:0016344 |
meiotic chromosome movement towards spindle pole(GO:0016344) |
| 0.4 |
2.3 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.4 |
1.9 |
GO:0045716 |
positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 |
1.1 |
GO:0002439 |
chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 0.4 |
1.9 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.4 |
0.4 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.4 |
2.2 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.4 |
0.4 |
GO:0009415 |
response to water(GO:0009415) |
| 0.4 |
1.5 |
GO:0016259 |
selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.4 |
2.9 |
GO:0061084 |
negative regulation of protein refolding(GO:0061084) |
| 0.4 |
1.8 |
GO:0042536 |
negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
| 0.4 |
0.4 |
GO:0046949 |
fatty-acyl-CoA biosynthetic process(GO:0046949) |
| 0.4 |
2.2 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.4 |
2.5 |
GO:1904016 |
response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
| 0.4 |
1.1 |
GO:0021649 |
vestibulocochlear nerve structural organization(GO:0021649) ganglion morphogenesis(GO:0061552) dorsal root ganglion morphogenesis(GO:1904835) |
| 0.4 |
2.5 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.4 |
2.1 |
GO:1903899 |
positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
| 0.4 |
1.1 |
GO:1903334 |
positive regulation of protein folding(GO:1903334) |
| 0.4 |
2.1 |
GO:2000211 |
regulation of glutamate metabolic process(GO:2000211) |
| 0.4 |
3.2 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.4 |
0.4 |
GO:0042668 |
auditory receptor cell fate determination(GO:0042668) |
| 0.4 |
1.4 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.4 |
0.7 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 0.3 |
2.1 |
GO:0072086 |
specification of loop of Henle identity(GO:0072086) |
| 0.3 |
4.2 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.3 |
2.4 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.3 |
1.4 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.3 |
1.7 |
GO:2000630 |
positive regulation of miRNA metabolic process(GO:2000630) |
| 0.3 |
1.0 |
GO:1903048 |
regulation of acetylcholine-gated cation channel activity(GO:1903048) |
| 0.3 |
0.3 |
GO:0051305 |
chromosome movement towards spindle pole(GO:0051305) |
| 0.3 |
1.4 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.3 |
0.3 |
GO:0060027 |
convergent extension involved in gastrulation(GO:0060027) |
| 0.3 |
2.0 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.3 |
2.0 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 0.3 |
1.3 |
GO:0097026 |
dendritic cell dendrite assembly(GO:0097026) |
| 0.3 |
0.7 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
1.0 |
GO:0071707 |
immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.3 |
0.3 |
GO:0003342 |
proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.3 |
1.6 |
GO:1904970 |
brush border assembly(GO:1904970) |
| 0.3 |
2.0 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.3 |
1.0 |
GO:0030450 |
regulation of complement activation, classical pathway(GO:0030450) |
| 0.3 |
1.3 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.3 |
1.0 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.3 |
1.0 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.3 |
1.3 |
GO:1903416 |
response to glycoside(GO:1903416) |
| 0.3 |
1.9 |
GO:0071630 |
nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.3 |
1.3 |
GO:1903750 |
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903750) negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:1903751) |
| 0.3 |
5.1 |
GO:0030828 |
positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.3 |
3.8 |
GO:0070131 |
positive regulation of mitochondrial translation(GO:0070131) |
| 0.3 |
4.1 |
GO:0021684 |
cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.3 |
8.2 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.3 |
1.9 |
GO:0006616 |
SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.3 |
3.8 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.3 |
0.3 |
GO:0061312 |
BMP signaling pathway involved in heart development(GO:0061312) |
| 0.3 |
3.1 |
GO:0072642 |
type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.3 |
0.9 |
GO:0040010 |
positive regulation of growth rate(GO:0040010) |
| 0.3 |
2.8 |
GO:0045176 |
apical protein localization(GO:0045176) |
| 0.3 |
2.2 |
GO:0032377 |
regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.3 |
1.5 |
GO:0006189 |
'de novo' IMP biosynthetic process(GO:0006189) |
| 0.3 |
0.6 |
GO:0070814 |
hydrogen sulfide biosynthetic process(GO:0070814) |
| 0.3 |
3.1 |
GO:0061727 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.3 |
4.0 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.3 |
3.4 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.3 |
2.4 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 0.3 |
0.3 |
GO:0006987 |
activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.3 |
1.8 |
GO:0009092 |
homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
| 0.3 |
1.8 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.3 |
0.9 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.3 |
1.5 |
GO:0061734 |
parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.3 |
0.9 |
GO:2001273 |
regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.3 |
0.3 |
GO:0048382 |
mesendoderm development(GO:0048382) |
| 0.3 |
0.9 |
GO:0032058 |
positive regulation of translational initiation in response to stress(GO:0032058) |
| 0.3 |
0.9 |
GO:0048807 |
female genitalia morphogenesis(GO:0048807) |
| 0.3 |
3.9 |
GO:0072502 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
0.9 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.3 |
0.6 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.3 |
1.2 |
GO:0097577 |
intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 0.3 |
1.4 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.3 |
0.9 |
GO:1900477 |
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
| 0.3 |
1.7 |
GO:1990564 |
protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.3 |
0.3 |
GO:0033128 |
negative regulation of histone phosphorylation(GO:0033128) |
| 0.3 |
0.9 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.3 |
0.9 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.3 |
1.4 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.3 |
1.1 |
GO:1904457 |
positive regulation of neuronal action potential(GO:1904457) |
| 0.3 |
3.1 |
GO:0090003 |
regulation of Golgi to plasma membrane protein transport(GO:0042996) regulation of establishment of protein localization to plasma membrane(GO:0090003) |
| 0.3 |
3.7 |
GO:0006855 |
drug transmembrane transport(GO:0006855) |
| 0.3 |
0.6 |
GO:1905051 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.3 |
0.8 |
GO:0090158 |
endoplasmic reticulum membrane organization(GO:0090158) |
| 0.3 |
0.6 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.3 |
2.8 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.3 |
0.8 |
GO:0070093 |
negative regulation of glucagon secretion(GO:0070093) |
| 0.3 |
1.4 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.3 |
1.1 |
GO:1902037 |
negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 0.3 |
1.9 |
GO:0030242 |
pexophagy(GO:0030242) |
| 0.3 |
0.8 |
GO:1900039 |
positive regulation of cellular response to hypoxia(GO:1900039) |
| 0.3 |
1.4 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.3 |
0.3 |
GO:0046121 |
deoxyribonucleoside catabolic process(GO:0046121) |
| 0.3 |
1.9 |
GO:0061732 |
mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.3 |
0.5 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.3 |
0.8 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
0.8 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.3 |
1.6 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.3 |
0.5 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.3 |
1.4 |
GO:0097118 |
neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
| 0.3 |
0.8 |
GO:0072734 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 |
0.5 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.3 |
1.3 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.3 |
1.3 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.3 |
2.1 |
GO:0009071 |
serine family amino acid catabolic process(GO:0009071) |
| 0.3 |
0.8 |
GO:1903551 |
regulation of extracellular exosome assembly(GO:1903551) |
| 0.3 |
4.0 |
GO:0097502 |
mannosylation(GO:0097502) |
| 0.3 |
0.5 |
GO:0070104 |
negative regulation of interleukin-6-mediated signaling pathway(GO:0070104) |
| 0.3 |
0.8 |
GO:0046341 |
CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.3 |
0.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
2.9 |
GO:0055089 |
fatty acid homeostasis(GO:0055089) |
| 0.3 |
1.3 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.3 |
1.6 |
GO:1901911 |
diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.3 |
2.9 |
GO:0090503 |
RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
| 0.3 |
0.8 |
GO:1902949 |
positive regulation of tau-protein kinase activity(GO:1902949) |
| 0.3 |
0.8 |
GO:0001982 |
baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
| 0.3 |
0.8 |
GO:0009188 |
ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 0.3 |
0.5 |
GO:0097360 |
chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
| 0.3 |
0.3 |
GO:1990927 |
calcium ion regulated lysosome exocytosis(GO:1990927) |
| 0.3 |
0.8 |
GO:2000744 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.3 |
1.3 |
GO:0038108 |
negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.3 |
0.8 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 |
1.3 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
0.3 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.3 |
1.3 |
GO:0034773 |
histone H4-K20 trimethylation(GO:0034773) |
| 0.3 |
4.5 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.3 |
0.8 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.3 |
0.8 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 |
0.5 |
GO:0097694 |
establishment of RNA localization to telomere(GO:0097694) |
| 0.3 |
3.0 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.3 |
1.0 |
GO:0044268 |
multicellular organismal protein metabolic process(GO:0044268) |
| 0.2 |
1.0 |
GO:0061030 |
epithelial cell differentiation involved in mammary gland alveolus development(GO:0061030) |
| 0.2 |
0.2 |
GO:0021815 |
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 0.2 |
0.7 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.2 |
0.5 |
GO:0009106 |
lipoate metabolic process(GO:0009106) |
| 0.2 |
0.7 |
GO:0060336 |
negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
| 0.2 |
2.0 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.2 |
0.7 |
GO:0035962 |
response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.2 |
2.7 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.2 |
2.4 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 |
0.5 |
GO:0042126 |
nitrate metabolic process(GO:0042126) |
| 0.2 |
1.7 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.2 |
1.2 |
GO:0002121 |
inter-male aggressive behavior(GO:0002121) |
| 0.2 |
2.2 |
GO:1900034 |
regulation of cellular response to heat(GO:1900034) |
| 0.2 |
1.2 |
GO:0060447 |
bud outgrowth involved in lung branching(GO:0060447) |
| 0.2 |
0.5 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.2 |
1.0 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.2 |
1.2 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 0.2 |
0.7 |
GO:0046103 |
adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.2 |
1.7 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.2 |
0.7 |
GO:0002014 |
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure(GO:0002014) |
| 0.2 |
0.7 |
GO:0043323 |
positive regulation of natural killer cell degranulation(GO:0043323) |
| 0.2 |
1.4 |
GO:0051036 |
regulation of endosome size(GO:0051036) |
| 0.2 |
1.2 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.2 |
0.2 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.2 |
0.2 |
GO:1901630 |
negative regulation of presynaptic membrane organization(GO:1901630) |
| 0.2 |
1.2 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.2 |
0.7 |
GO:0038165 |
oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 |
6.0 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.2 |
1.2 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.2 |
0.5 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.2 |
0.5 |
GO:0015746 |
tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 |
3.0 |
GO:0042407 |
cristae formation(GO:0042407) |
| 0.2 |
1.6 |
GO:0017196 |
N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.2 |
3.7 |
GO:0051608 |
histamine transport(GO:0051608) |
| 0.2 |
1.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.2 |
0.9 |
GO:2000182 |
regulation of progesterone biosynthetic process(GO:2000182) |
| 0.2 |
2.1 |
GO:0031666 |
positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
| 0.2 |
0.5 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.2 |
5.2 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.2 |
0.7 |
GO:0070900 |
mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.2 |
0.7 |
GO:0045645 |
regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 |
0.4 |
GO:1903542 |
negative regulation of exosomal secretion(GO:1903542) |
| 0.2 |
0.4 |
GO:0033092 |
positive regulation of immature T cell proliferation in thymus(GO:0033092) |
| 0.2 |
0.7 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.2 |
0.7 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.2 |
3.1 |
GO:0002328 |
pro-B cell differentiation(GO:0002328) |
| 0.2 |
0.2 |
GO:0045632 |
negative regulation of auditory receptor cell differentiation(GO:0045608) negative regulation of mechanoreceptor differentiation(GO:0045632) negative regulation of inner ear receptor cell differentiation(GO:2000981) |
| 0.2 |
0.4 |
GO:0070368 |
positive regulation of hepatocyte differentiation(GO:0070368) |
| 0.2 |
1.3 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.2 |
0.4 |
GO:0032237 |
activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
| 0.2 |
0.7 |
GO:0044240 |
multicellular organism lipid catabolic process(GO:0044240) |
| 0.2 |
0.2 |
GO:1904580 |
regulation of intracellular mRNA localization(GO:1904580) |
| 0.2 |
1.5 |
GO:2000189 |
positive regulation of cholesterol homeostasis(GO:2000189) |
| 0.2 |
0.9 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.2 |
0.7 |
GO:1901896 |
positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 0.2 |
2.8 |
GO:0051967 |
negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.2 |
3.0 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.2 |
0.9 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.2 |
1.9 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.2 |
1.1 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.2 |
1.9 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.2 |
0.4 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.2 |
0.6 |
GO:0055099 |
response to high density lipoprotein particle(GO:0055099) |
| 0.2 |
1.9 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) |
| 0.2 |
0.6 |
GO:0051030 |
snRNA transport(GO:0051030) |
| 0.2 |
0.6 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.2 |
1.0 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
1.5 |
GO:0031468 |
nuclear envelope reassembly(GO:0031468) |
| 0.2 |
0.8 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.2 |
0.4 |
GO:0007262 |
STAT protein import into nucleus(GO:0007262) |
| 0.2 |
0.4 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.2 |
0.8 |
GO:1905247 |
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
| 0.2 |
1.0 |
GO:0070141 |
response to UV-A(GO:0070141) |
| 0.2 |
0.4 |
GO:0036112 |
medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.2 |
0.8 |
GO:1900739 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.2 |
0.6 |
GO:0045204 |
MAPK export from nucleus(GO:0045204) |
| 0.2 |
0.2 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.2 |
1.4 |
GO:0060613 |
fat pad development(GO:0060613) |
| 0.2 |
0.4 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
| 0.2 |
0.2 |
GO:0046619 |
optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.2 |
1.2 |
GO:0019805 |
quinolinate biosynthetic process(GO:0019805) |
| 0.2 |
0.6 |
GO:0090650 |
response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
| 0.2 |
0.2 |
GO:0002572 |
pro-T cell differentiation(GO:0002572) |
| 0.2 |
1.6 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) |
| 0.2 |
1.4 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.2 |
0.6 |
GO:0060060 |
post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
| 0.2 |
1.2 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) |
| 0.2 |
1.0 |
GO:1903677 |
regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 |
2.0 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.2 |
0.8 |
GO:0060416 |
response to growth hormone(GO:0060416) |
| 0.2 |
1.2 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.6 |
GO:0000957 |
mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.2 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.2 |
2.0 |
GO:1990440 |
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
| 0.2 |
1.2 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.2 |
2.3 |
GO:0034626 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.2 |
1.2 |
GO:0031999 |
negative regulation of fatty acid beta-oxidation(GO:0031999) |
| 0.2 |
0.2 |
GO:1903626 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 |
1.6 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 |
0.6 |
GO:1990859 |
cellular response to endothelin(GO:1990859) |
| 0.2 |
1.4 |
GO:0070777 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 |
2.3 |
GO:0070673 |
response to interleukin-18(GO:0070673) |
| 0.2 |
1.0 |
GO:2000601 |
positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
| 0.2 |
0.6 |
GO:0001180 |
transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 |
2.1 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.2 |
0.6 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.2 |
0.8 |
GO:0035519 |
protein K29-linked ubiquitination(GO:0035519) |
| 0.2 |
0.8 |
GO:0006421 |
asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.2 |
7.9 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.2 |
0.2 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.2 |
0.9 |
GO:0048875 |
chemical homeostasis within a tissue(GO:0048875) |
| 0.2 |
0.6 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.2 |
3.4 |
GO:0006515 |
misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
| 0.2 |
0.7 |
GO:0030091 |
protein repair(GO:0030091) |
| 0.2 |
0.9 |
GO:0006527 |
arginine catabolic process(GO:0006527) |
| 0.2 |
0.4 |
GO:1990401 |
embryonic lung development(GO:1990401) |
| 0.2 |
2.4 |
GO:0043517 |
positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.2 |
1.7 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.2 |
GO:0006114 |
glycerol biosynthetic process(GO:0006114) alditol biosynthetic process(GO:0019401) |
| 0.2 |
6.9 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.2 |
1.3 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.2 |
1.8 |
GO:0031340 |
positive regulation of vesicle fusion(GO:0031340) |
| 0.2 |
0.9 |
GO:1905150 |
regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.2 |
0.2 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
0.4 |
GO:0035983 |
response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
| 0.2 |
0.6 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.2 |
0.6 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.2 |
0.2 |
GO:0061141 |
lung ciliated cell differentiation(GO:0061141) |
| 0.2 |
0.4 |
GO:0060849 |
regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.2 |
0.5 |
GO:0010814 |
substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.2 |
0.7 |
GO:0021798 |
forebrain dorsal/ventral pattern formation(GO:0021798) |
| 0.2 |
0.9 |
GO:0075509 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.2 |
2.7 |
GO:0055070 |
copper ion homeostasis(GO:0055070) |
| 0.2 |
1.6 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.2 |
2.2 |
GO:0098787 |
mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.2 |
0.5 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.2 |
0.2 |
GO:0006106 |
fumarate metabolic process(GO:0006106) |
| 0.2 |
0.5 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.2 |
4.3 |
GO:0007184 |
SMAD protein import into nucleus(GO:0007184) |
| 0.2 |
0.9 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.2 |
1.8 |
GO:0030948 |
negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 |
0.2 |
GO:1904628 |
response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 0.2 |
0.4 |
GO:0038018 |
Wnt receptor catabolic process(GO:0038018) |
| 0.2 |
2.9 |
GO:0000338 |
protein deneddylation(GO:0000338) |
| 0.2 |
0.7 |
GO:1900224 |
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
| 0.2 |
0.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.2 |
0.4 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.2 |
0.7 |
GO:0090289 |
regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
| 0.2 |
0.4 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.2 |
3.9 |
GO:0015936 |
coenzyme A metabolic process(GO:0015936) |
| 0.2 |
0.5 |
GO:0061625 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 |
0.7 |
GO:0006627 |
protein processing involved in protein targeting to mitochondrion(GO:0006627) |
| 0.2 |
1.6 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.2 |
0.9 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.2 |
2.4 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.7 |
GO:0006152 |
purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
| 0.2 |
0.3 |
GO:0070086 |
ubiquitin-dependent endocytosis(GO:0070086) |
| 0.2 |
0.3 |
GO:0032055 |
negative regulation of translation in response to stress(GO:0032055) |
| 0.2 |
0.5 |
GO:0032470 |
positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) |
| 0.2 |
0.7 |
GO:0007198 |
adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.2 |
1.0 |
GO:0045630 |
positive regulation of T-helper 2 cell differentiation(GO:0045630) |
| 0.2 |
0.7 |
GO:1900227 |
positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
| 0.2 |
1.4 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
2.2 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.2 |
2.4 |
GO:0090261 |
positive regulation of inclusion body assembly(GO:0090261) |
| 0.2 |
0.7 |
GO:0072344 |
rescue of stalled ribosome(GO:0072344) |
| 0.2 |
0.5 |
GO:2000847 |
negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
| 0.2 |
1.2 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 |
0.5 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.2 |
0.7 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.2 |
3.2 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.5 |
GO:0006084 |
acetyl-CoA metabolic process(GO:0006084) |
| 0.2 |
0.5 |
GO:0046666 |
retinal cell programmed cell death(GO:0046666) |
| 0.2 |
1.7 |
GO:0031119 |
tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 |
1.3 |
GO:0002934 |
desmosome organization(GO:0002934) |
| 0.2 |
0.7 |
GO:1990022 |
RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 |
0.2 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.2 |
0.7 |
GO:0021836 |
chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) |
| 0.2 |
1.3 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.2 |
0.5 |
GO:0031161 |
phosphatidylinositol catabolic process(GO:0031161) |
| 0.2 |
0.2 |
GO:0072181 |
mesonephric duct formation(GO:0072181) |
| 0.2 |
0.3 |
GO:0070427 |
nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
| 0.2 |
0.6 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 |
0.2 |
GO:1900150 |
regulation of defense response to fungus(GO:1900150) |
| 0.2 |
0.3 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.2 |
0.5 |
GO:0043686 |
co-translational protein modification(GO:0043686) |
| 0.2 |
1.0 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.5 |
GO:1904978 |
regulation of endosome organization(GO:1904978) positive regulation of endosome organization(GO:1904980) |
| 0.2 |
3.4 |
GO:0099517 |
anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.2 |
0.6 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
2.4 |
GO:0071420 |
cellular response to histamine(GO:0071420) |
| 0.2 |
2.4 |
GO:0043248 |
proteasome assembly(GO:0043248) |
| 0.2 |
1.9 |
GO:0050667 |
homocysteine metabolic process(GO:0050667) |
| 0.2 |
0.6 |
GO:1902626 |
assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.2 |
0.2 |
GO:1990791 |
dorsal root ganglion development(GO:1990791) |
| 0.2 |
0.9 |
GO:0021830 |
interneuron migration from the subpallium to the cortex(GO:0021830) |
| 0.2 |
0.5 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.2 |
0.3 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.2 |
0.5 |
GO:0046271 |
phenylpropanoid catabolic process(GO:0046271) olefin metabolic process(GO:1900673) |
| 0.2 |
0.3 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.2 |
0.2 |
GO:0090526 |
regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
| 0.2 |
0.9 |
GO:1990573 |
potassium ion import across plasma membrane(GO:1990573) |
| 0.2 |
0.9 |
GO:0098961 |
dendritic transport of ribonucleoprotein complex(GO:0098961) dendritic transport of messenger ribonucleoprotein complex(GO:0098963) anterograde dendritic transport of messenger ribonucleoprotein complex(GO:0098964) |
| 0.2 |
1.8 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 |
0.8 |
GO:0018992 |
germ-line sex determination(GO:0018992) |
| 0.2 |
0.3 |
GO:1903348 |
positive regulation of bicellular tight junction assembly(GO:1903348) |
| 0.2 |
1.2 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 |
0.8 |
GO:0034627 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.2 |
1.1 |
GO:0033132 |
negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.2 |
0.8 |
GO:2000562 |
negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
| 0.2 |
0.8 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.2 |
1.1 |
GO:0010990 |
regulation of SMAD protein complex assembly(GO:0010990) |
| 0.2 |
0.6 |
GO:0090360 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 |
0.5 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.2 |
8.6 |
GO:0070936 |
protein K48-linked ubiquitination(GO:0070936) |
| 0.2 |
0.5 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.2 |
0.5 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.1 |
0.4 |
GO:0060715 |
syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 0.1 |
0.3 |
GO:1901421 |
positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
0.6 |
GO:0032511 |
late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.1 |
0.6 |
GO:1901492 |
positive regulation of lymphangiogenesis(GO:1901492) |
| 0.1 |
3.0 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
2.8 |
GO:0006101 |
citrate metabolic process(GO:0006101) |
| 0.1 |
0.4 |
GO:2001160 |
regulation of histone H3-K79 methylation(GO:2001160) |
| 0.1 |
1.0 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.6 |
GO:1904715 |
negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 0.1 |
1.5 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.1 |
0.3 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.1 |
0.4 |
GO:0048840 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.1 |
0.6 |
GO:0006030 |
chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.1 |
0.4 |
GO:0071947 |
protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 |
0.4 |
GO:0048698 |
negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.1 |
0.9 |
GO:0051096 |
regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
| 0.1 |
0.1 |
GO:2000832 |
negative regulation of steroid hormone secretion(GO:2000832) |
| 0.1 |
0.6 |
GO:0060598 |
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 0.1 |
0.6 |
GO:1902261 |
positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 0.1 |
0.9 |
GO:1902513 |
regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 |
0.3 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.1 |
1.0 |
GO:0034196 |
acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.1 |
0.4 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 |
0.3 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.4 |
GO:0006011 |
UDP-glucose metabolic process(GO:0006011) |
| 0.1 |
0.3 |
GO:0000715 |
nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.1 |
0.4 |
GO:0019853 |
L-ascorbic acid biosynthetic process(GO:0019853) |
| 0.1 |
1.7 |
GO:0090110 |
cargo loading into COPII-coated vesicle(GO:0090110) |
| 0.1 |
0.3 |
GO:0007227 |
signal transduction downstream of smoothened(GO:0007227) positive regulation of hh target transcription factor activity(GO:0007228) |
| 0.1 |
1.4 |
GO:1901409 |
positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
0.4 |
GO:0060167 |
regulation of adenosine receptor signaling pathway(GO:0060167) positive regulation of adenosine receptor signaling pathway(GO:0060168) |
| 0.1 |
0.4 |
GO:0043653 |
mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.1 |
0.7 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.1 |
0.7 |
GO:0071557 |
histone H3-K27 demethylation(GO:0071557) |
| 0.1 |
0.3 |
GO:0000965 |
mitochondrial RNA 3'-end processing(GO:0000965) |
| 0.1 |
0.3 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.8 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.3 |
GO:1900108 |
negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 |
0.8 |
GO:0009146 |
purine nucleoside triphosphate catabolic process(GO:0009146) |
| 0.1 |
0.7 |
GO:0051387 |
negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
| 0.1 |
1.1 |
GO:0016556 |
mRNA modification(GO:0016556) |
| 0.1 |
0.4 |
GO:0030497 |
fatty acid elongation(GO:0030497) |
| 0.1 |
0.1 |
GO:2001271 |
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
3.5 |
GO:0015986 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
1.0 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.1 |
0.4 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.4 |
GO:0003219 |
cardiac right ventricle formation(GO:0003219) |
| 0.1 |
1.0 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.1 |
0.4 |
GO:0045084 |
positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.1 |
1.7 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.1 |
0.5 |
GO:0001880 |
Mullerian duct regression(GO:0001880) |
| 0.1 |
1.5 |
GO:0070072 |
vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
| 0.1 |
0.9 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
1.7 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.1 |
0.8 |
GO:0039702 |
viral budding via host ESCRT complex(GO:0039702) |
| 0.1 |
0.7 |
GO:1903541 |
regulation of exosomal secretion(GO:1903541) positive regulation of exosomal secretion(GO:1903543) |
| 0.1 |
0.9 |
GO:0090230 |
regulation of centromere complex assembly(GO:0090230) |
| 0.1 |
0.4 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.1 |
0.7 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 |
0.4 |
GO:0051935 |
amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) |
| 0.1 |
0.9 |
GO:1990009 |
retinal cell apoptotic process(GO:1990009) |
| 0.1 |
0.1 |
GO:0045358 |
negative regulation of interferon-beta biosynthetic process(GO:0045358) |
| 0.1 |
1.2 |
GO:0001842 |
neural fold formation(GO:0001842) |
| 0.1 |
2.1 |
GO:2000772 |
regulation of cellular senescence(GO:2000772) |
| 0.1 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.1 |
0.4 |
GO:0098974 |
postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.1 |
0.4 |
GO:0021849 |
neuroblast division in subventricular zone(GO:0021849) |
| 0.1 |
1.8 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.4 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.6 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
0.3 |
GO:0034983 |
peptidyl-lysine deacetylation(GO:0034983) |
| 0.1 |
0.4 |
GO:0001192 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.1 |
0.6 |
GO:1901509 |
regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.1 |
0.4 |
GO:0070601 |
centromeric sister chromatid cohesion(GO:0070601) |
| 0.1 |
1.2 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
4.4 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
0.6 |
GO:1904953 |
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) |
| 0.1 |
1.4 |
GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
| 0.1 |
0.8 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.1 |
1.5 |
GO:0033617 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.1 |
0.5 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.1 |
0.4 |
GO:0018199 |
peptidyl-glutamine modification(GO:0018199) |
| 0.1 |
0.8 |
GO:0060178 |
regulation of exocyst localization(GO:0060178) |
| 0.1 |
0.5 |
GO:0070634 |
transepithelial ammonium transport(GO:0070634) |
| 0.1 |
4.1 |
GO:0010257 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.1 |
0.6 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.1 |
0.5 |
GO:1990928 |
response to amino acid starvation(GO:1990928) |
| 0.1 |
0.2 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.1 |
0.5 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.1 |
1.5 |
GO:0006991 |
response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
| 0.1 |
0.2 |
GO:0061073 |
ciliary body morphogenesis(GO:0061073) |
| 0.1 |
0.9 |
GO:1903689 |
regulation of wound healing, spreading of epidermal cells(GO:1903689) positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.1 |
0.2 |
GO:0015889 |
cobalamin transport(GO:0015889) |
| 0.1 |
1.2 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.1 |
0.5 |
GO:0019359 |
nicotinamide nucleotide biosynthetic process(GO:0019359) |
| 0.1 |
0.2 |
GO:1904948 |
midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.1 |
2.3 |
GO:0042178 |
xenobiotic catabolic process(GO:0042178) |
| 0.1 |
1.0 |
GO:0045947 |
negative regulation of translational initiation(GO:0045947) |
| 0.1 |
1.3 |
GO:0010452 |
histone H3-K36 methylation(GO:0010452) |
| 0.1 |
0.5 |
GO:0071638 |
negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
| 0.1 |
1.3 |
GO:0018230 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.1 |
0.2 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
0.4 |
GO:2000393 |
negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.1 |
1.8 |
GO:2000060 |
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
| 0.1 |
0.1 |
GO:0097374 |
sensory neuron axon guidance(GO:0097374) |
| 0.1 |
1.3 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
6.7 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.1 |
0.8 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.1 |
0.5 |
GO:0007000 |
nucleolus organization(GO:0007000) |
| 0.1 |
0.4 |
GO:0051561 |
positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.1 |
0.4 |
GO:0060912 |
cardiac cell fate specification(GO:0060912) |
| 0.1 |
0.5 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.1 |
0.5 |
GO:0045994 |
regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
| 0.1 |
1.2 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
0.2 |
GO:0021773 |
striatal medium spiny neuron differentiation(GO:0021773) |
| 0.1 |
0.5 |
GO:0048597 |
post-embryonic eye morphogenesis(GO:0048050) post-embryonic camera-type eye morphogenesis(GO:0048597) |
| 0.1 |
0.4 |
GO:0010693 |
negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.1 |
0.1 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.1 |
0.6 |
GO:0006983 |
ER overload response(GO:0006983) |
| 0.1 |
0.1 |
GO:0046060 |
dATP metabolic process(GO:0046060) |
| 0.1 |
0.4 |
GO:0000237 |
leptotene(GO:0000237) |
| 0.1 |
0.3 |
GO:0044828 |
negative regulation by host of viral genome replication(GO:0044828) |
| 0.1 |
0.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
1.2 |
GO:0042359 |
vitamin D metabolic process(GO:0042359) |
| 0.1 |
0.3 |
GO:1903069 |
regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
| 0.1 |
0.5 |
GO:0046719 |
regulation by virus of viral protein levels in host cell(GO:0046719) |
| 0.1 |
0.3 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.1 |
0.8 |
GO:0033227 |
dsRNA transport(GO:0033227) |
| 0.1 |
0.5 |
GO:2000324 |
positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 |
0.3 |
GO:1904754 |
positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
| 0.1 |
1.2 |
GO:0048619 |
embryonic hindgut morphogenesis(GO:0048619) |
| 0.1 |
1.6 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.1 |
0.3 |
GO:0035610 |
protein side chain deglutamylation(GO:0035610) |
| 0.1 |
1.4 |
GO:0042347 |
negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.1 |
0.5 |
GO:0042045 |
epithelial fluid transport(GO:0042045) |
| 0.1 |
1.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.1 |
0.2 |
GO:0046462 |
monoacylglycerol metabolic process(GO:0046462) |
| 0.1 |
0.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.1 |
0.8 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
1.3 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
0.8 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 |
0.4 |
GO:0061760 |
antifungal innate immune response(GO:0061760) |
| 0.1 |
0.6 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.7 |
GO:0001575 |
globoside metabolic process(GO:0001575) |
| 0.1 |
0.9 |
GO:0001915 |
negative regulation of T cell mediated cytotoxicity(GO:0001915) |
| 0.1 |
0.2 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.7 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.3 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.1 |
0.4 |
GO:0060158 |
phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
| 0.1 |
1.2 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.1 |
0.4 |
GO:1902045 |
regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
| 0.1 |
0.9 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
0.4 |
GO:0015827 |
aromatic amino acid transport(GO:0015801) tryptophan transport(GO:0015827) |
| 0.1 |
1.1 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
2.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
0.5 |
GO:0044597 |
polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.1 |
0.4 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.5 |
GO:0035435 |
phosphate ion transmembrane transport(GO:0035435) |
| 0.1 |
0.6 |
GO:0035284 |
central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
| 0.1 |
0.7 |
GO:0021912 |
regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.1 |
0.4 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.1 |
0.3 |
GO:0015881 |
creatine transport(GO:0015881) |
| 0.1 |
2.4 |
GO:0070884 |
regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
| 0.1 |
1.4 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.1 |
0.2 |
GO:2000790 |
mesenchymal cell proliferation involved in lung development(GO:0060916) regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
| 0.1 |
0.4 |
GO:0046337 |
phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.1 |
0.4 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.1 |
0.4 |
GO:0070317 |
negative regulation of G0 to G1 transition(GO:0070317) |
| 0.1 |
1.7 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 |
0.6 |
GO:0009235 |
cobalamin metabolic process(GO:0009235) |
| 0.1 |
0.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.9 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
0.5 |
GO:0002756 |
MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.1 |
0.4 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.5 |
GO:0032915 |
positive regulation of transforming growth factor beta2 production(GO:0032915) |
| 0.1 |
0.3 |
GO:1900747 |
negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 |
0.3 |
GO:0034141 |
positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 0.1 |
0.9 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.1 |
0.1 |
GO:1902525 |
regulation of protein monoubiquitination(GO:1902525) |
| 0.1 |
0.3 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.9 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.1 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.3 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.1 |
0.1 |
GO:1903332 |
regulation of protein folding(GO:1903332) |
| 0.1 |
0.2 |
GO:0044878 |
mitotic cytokinesis checkpoint(GO:0044878) |
| 0.1 |
0.3 |
GO:0070212 |
protein poly-ADP-ribosylation(GO:0070212) |
| 0.1 |
4.7 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.1 |
0.9 |
GO:2000580 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 |
0.7 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 |
0.4 |
GO:0071431 |
tRNA export from nucleus(GO:0006409) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.1 |
0.5 |
GO:0051012 |
microtubule sliding(GO:0051012) |
| 0.1 |
0.1 |
GO:0021826 |
substrate-independent telencephalic tangential migration(GO:0021826) substrate-independent telencephalic tangential interneuron migration(GO:0021843) |
| 0.1 |
0.7 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.1 |
0.3 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.4 |
GO:0035865 |
response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.5 |
GO:0090153 |
regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.1 |
0.3 |
GO:0097534 |
lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) |
| 0.1 |
1.8 |
GO:0008272 |
sulfate transport(GO:0008272) |
| 0.1 |
0.4 |
GO:0035720 |
intraciliary anterograde transport(GO:0035720) |
| 0.1 |
0.1 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.1 |
1.9 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
0.8 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.1 |
0.4 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.1 |
1.1 |
GO:1903427 |
negative regulation of reactive oxygen species biosynthetic process(GO:1903427) |
| 0.1 |
0.4 |
GO:0003050 |
regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.1 |
0.5 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
3.2 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.1 |
0.7 |
GO:0043562 |
cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 |
0.3 |
GO:1901628 |
positive regulation of postsynaptic membrane organization(GO:1901628) positive regulation of receptor clustering(GO:1903911) |
| 0.1 |
0.6 |
GO:0045794 |
negative regulation of cell volume(GO:0045794) |
| 0.1 |
0.3 |
GO:0071830 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.1 |
0.3 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.1 |
3.8 |
GO:0043171 |
peptide catabolic process(GO:0043171) |
| 0.1 |
2.2 |
GO:0009395 |
phospholipid catabolic process(GO:0009395) |
| 0.1 |
0.2 |
GO:0046877 |
regulation of saliva secretion(GO:0046877) |
| 0.1 |
2.1 |
GO:0050779 |
RNA destabilization(GO:0050779) |
| 0.1 |
0.7 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.1 |
2.6 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.1 |
0.7 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.1 |
0.5 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.1 |
0.7 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.1 |
0.4 |
GO:0034350 |
regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
| 0.1 |
0.3 |
GO:1902871 |
cerebral cortex GABAergic interneuron fate commitment(GO:0021893) positive regulation of neural retina development(GO:0061075) positive regulation of retina development in camera-type eye(GO:1902868) positive regulation of amacrine cell differentiation(GO:1902871) |
| 0.1 |
0.3 |
GO:0014022 |
neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.1 |
0.8 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
1.1 |
GO:0048853 |
forebrain morphogenesis(GO:0048853) |
| 0.1 |
0.4 |
GO:0035553 |
oxidative single-stranded RNA demethylation(GO:0035553) |
| 0.1 |
1.6 |
GO:0045723 |
positive regulation of fatty acid biosynthetic process(GO:0045723) |
| 0.1 |
0.7 |
GO:0090042 |
tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
| 0.1 |
0.3 |
GO:0014878 |
response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
| 0.1 |
0.5 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.1 |
0.2 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.1 |
1.1 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.3 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 0.1 |
0.5 |
GO:0032483 |
regulation of Rab protein signal transduction(GO:0032483) |
| 0.1 |
1.9 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.1 |
0.5 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.1 |
0.5 |
GO:0042276 |
error-prone translesion synthesis(GO:0042276) |
| 0.1 |
0.3 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.2 |
GO:0072695 |
negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
| 0.1 |
2.8 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.8 |
GO:0043508 |
negative regulation of JUN kinase activity(GO:0043508) |
| 0.1 |
0.2 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.1 |
3.5 |
GO:0007029 |
endoplasmic reticulum organization(GO:0007029) |
| 0.1 |
0.3 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.1 |
2.4 |
GO:0007638 |
mechanosensory behavior(GO:0007638) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.2 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.1 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.2 |
GO:0052055 |
modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
| 0.1 |
0.8 |
GO:1903441 |
protein localization to ciliary membrane(GO:1903441) |
| 0.1 |
0.2 |
GO:0089700 |
protein kinase D signaling(GO:0089700) |
| 0.1 |
0.3 |
GO:0006041 |
glucosamine metabolic process(GO:0006041) |
| 0.1 |
0.5 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.1 |
0.2 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.1 |
0.6 |
GO:0097012 |
response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.1 |
0.7 |
GO:0070816 |
phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.1 |
1.5 |
GO:0060117 |
auditory receptor cell development(GO:0060117) |
| 0.1 |
0.2 |
GO:0021934 |
hindbrain tangential cell migration(GO:0021934) |
| 0.1 |
0.2 |
GO:0072396 |
response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.2 |
GO:0043144 |
snoRNA processing(GO:0043144) |
| 0.1 |
0.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.1 |
1.1 |
GO:0071554 |
cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
| 0.1 |
0.4 |
GO:0045631 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
0.7 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.1 |
0.6 |
GO:0009240 |
isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.1 |
0.9 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
0.5 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.1 |
0.7 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.1 |
0.2 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.1 |
0.6 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
0.2 |
GO:0015817 |
histidine transport(GO:0015817) |
| 0.1 |
1.0 |
GO:0023019 |
signal transduction involved in regulation of gene expression(GO:0023019) |
| 0.1 |
0.2 |
GO:0017187 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.1 |
0.2 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
1.2 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.2 |
GO:1990839 |
response to endothelin(GO:1990839) |
| 0.1 |
0.4 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.1 |
0.6 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.1 |
0.3 |
GO:0060332 |
positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
| 0.1 |
0.1 |
GO:2000843 |
testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 |
0.2 |
GO:0006534 |
cysteine metabolic process(GO:0006534) |
| 0.1 |
0.2 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 |
2.1 |
GO:0021904 |
dorsal/ventral neural tube patterning(GO:0021904) |
| 0.1 |
1.3 |
GO:0016339 |
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 |
1.1 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.1 |
1.0 |
GO:0046470 |
phosphatidylcholine metabolic process(GO:0046470) |
| 0.1 |
0.1 |
GO:0034372 |
triglyceride-rich lipoprotein particle remodeling(GO:0034370) very-low-density lipoprotein particle remodeling(GO:0034372) |
| 0.1 |
1.5 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.1 |
7.7 |
GO:0042787 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
| 0.1 |
0.3 |
GO:0033313 |
meiotic cell cycle checkpoint(GO:0033313) |
| 0.1 |
0.4 |
GO:0003283 |
atrial septum development(GO:0003283) |
| 0.1 |
0.4 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 |
0.7 |
GO:1900119 |
positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 |
0.1 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.3 |
GO:0050882 |
voluntary musculoskeletal movement(GO:0050882) |
| 0.1 |
0.1 |
GO:0015961 |
diadenosine polyphosphate catabolic process(GO:0015961) |
| 0.1 |
0.2 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
2.0 |
GO:0046856 |
phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.1 |
0.1 |
GO:0033108 |
mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.1 |
1.4 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 |
0.3 |
GO:0016128 |
phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.1 |
0.1 |
GO:0039530 |
MDA-5 signaling pathway(GO:0039530) regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.1 |
0.4 |
GO:2000483 |
negative regulation of interleukin-8 secretion(GO:2000483) |
| 0.1 |
0.6 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.3 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
3.3 |
GO:0010501 |
RNA secondary structure unwinding(GO:0010501) |
| 0.1 |
0.2 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.1 |
0.9 |
GO:0014887 |
cardiac muscle adaptation(GO:0014887) |
| 0.1 |
0.6 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 |
0.5 |
GO:0033182 |
regulation of histone ubiquitination(GO:0033182) |
| 0.1 |
0.7 |
GO:0019217 |
regulation of fatty acid metabolic process(GO:0019217) |
| 0.1 |
2.8 |
GO:0032543 |
mitochondrial translation(GO:0032543) |
| 0.1 |
0.5 |
GO:0045351 |
type I interferon biosynthetic process(GO:0045351) |
| 0.1 |
0.4 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.5 |
GO:0008105 |
asymmetric protein localization(GO:0008105) |
| 0.1 |
0.8 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 |
0.3 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.1 |
0.2 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 |
0.3 |
GO:0044351 |
macropinocytosis(GO:0044351) |
| 0.1 |
0.7 |
GO:0099563 |
modification of synaptic structure(GO:0099563) |
| 0.1 |
0.3 |
GO:0015846 |
polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
| 0.1 |
0.3 |
GO:0035606 |
peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.1 |
0.7 |
GO:0099515 |
actin filament-based transport(GO:0099515) |
| 0.1 |
1.4 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
0.1 |
GO:0033615 |
mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 |
0.6 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.1 |
0.2 |
GO:1900165 |
negative regulation of interleukin-6 secretion(GO:1900165) |
| 0.1 |
0.3 |
GO:0009052 |
pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.1 |
0.3 |
GO:0098914 |
membrane repolarization during atrial cardiac muscle cell action potential(GO:0098914) |
| 0.1 |
0.2 |
GO:0046459 |
short-chain fatty acid metabolic process(GO:0046459) |
| 0.1 |
0.6 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
0.3 |
GO:2000637 |
positive regulation of gene silencing by miRNA(GO:2000637) |
| 0.1 |
0.1 |
GO:1900620 |
acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
| 0.1 |
0.8 |
GO:0060119 |
inner ear receptor cell development(GO:0060119) |
| 0.1 |
0.1 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 0.1 |
0.2 |
GO:0072137 |
condensed mesenchymal cell proliferation(GO:0072137) |
| 0.1 |
0.1 |
GO:0090271 |
positive regulation of fibroblast growth factor production(GO:0090271) |
| 0.1 |
0.2 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.2 |
GO:1902166 |
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
| 0.1 |
0.3 |
GO:0061002 |
negative regulation of dendritic spine morphogenesis(GO:0061002) |
| 0.1 |
0.2 |
GO:0090394 |
negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.1 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
0.2 |
GO:0032801 |
receptor catabolic process(GO:0032801) |
| 0.1 |
1.4 |
GO:0046326 |
positive regulation of glucose import(GO:0046326) |
| 0.1 |
0.2 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.1 |
0.1 |
GO:0010808 |
positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.1 |
1.3 |
GO:0071108 |
protein K48-linked deubiquitination(GO:0071108) |
| 0.1 |
0.5 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
1.5 |
GO:0015988 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.1 |
0.4 |
GO:0015701 |
bicarbonate transport(GO:0015701) |
| 0.1 |
0.5 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.1 |
0.5 |
GO:0003179 |
heart valve morphogenesis(GO:0003179) |
| 0.1 |
0.2 |
GO:0097350 |
neutrophil clearance(GO:0097350) |
| 0.1 |
3.3 |
GO:0045454 |
cell redox homeostasis(GO:0045454) |
| 0.1 |
0.1 |
GO:0043400 |
cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
| 0.1 |
0.7 |
GO:0071361 |
cellular response to ethanol(GO:0071361) |
| 0.1 |
0.1 |
GO:0009204 |
deoxyribonucleoside triphosphate catabolic process(GO:0009204) |
| 0.1 |
0.5 |
GO:0045162 |
clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 |
1.0 |
GO:0034308 |
primary alcohol metabolic process(GO:0034308) |
| 0.1 |
0.1 |
GO:0033058 |
directional locomotion(GO:0033058) |
| 0.1 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.1 |
0.2 |
GO:1900037 |
regulation of cellular response to hypoxia(GO:1900037) |
| 0.1 |
0.4 |
GO:0015684 |
ferrous iron transport(GO:0015684) |
| 0.1 |
0.1 |
GO:0009223 |
pyrimidine nucleotide catabolic process(GO:0006244) pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.1 |
0.3 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
0.7 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.1 |
0.1 |
GO:0042033 |
chemokine biosynthetic process(GO:0042033) regulation of chemokine biosynthetic process(GO:0045073) negative regulation of chemokine biosynthetic process(GO:0045079) |
| 0.1 |
0.2 |
GO:0014850 |
response to muscle activity(GO:0014850) |
| 0.1 |
0.4 |
GO:0060768 |
regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
| 0.1 |
0.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.1 |
0.2 |
GO:0061668 |
mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.2 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.1 |
GO:2000382 |
positive regulation of mesoderm development(GO:2000382) |
| 0.1 |
2.1 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.1 |
0.5 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
0.3 |
GO:0045743 |
positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 |
0.3 |
GO:0000117 |
regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
| 0.1 |
0.2 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.1 |
0.1 |
GO:0090045 |
positive regulation of deacetylase activity(GO:0090045) |
| 0.1 |
0.2 |
GO:0099403 |
negative regulation of maintenance of sister chromatid cohesion(GO:0034092) negative regulation of maintenance of mitotic sister chromatid cohesion(GO:0034183) post-embryonic appendage morphogenesis(GO:0035120) post-embryonic limb morphogenesis(GO:0035127) post-embryonic forelimb morphogenesis(GO:0035128) telomeric repeat-containing RNA transcription(GO:0097393) telomeric repeat-containing RNA transcription from RNA pol II promoter(GO:0097394) maintenance of mitotic sister chromatid cohesion, telomeric(GO:0099403) mitotic sister chromatid cohesion, telomeric(GO:0099404) regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901580) negative regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901581) positive regulation of telomeric RNA transcription from RNA pol II promoter(GO:1901582) regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904907) negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric(GO:1904908) |
| 0.1 |
0.6 |
GO:1990126 |
retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 |
0.7 |
GO:0010613 |
positive regulation of cardiac muscle hypertrophy(GO:0010613) positive regulation of muscle hypertrophy(GO:0014742) |
| 0.1 |
0.2 |
GO:0006529 |
asparagine biosynthetic process(GO:0006529) |
| 0.1 |
0.2 |
GO:0061684 |
chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 |
0.2 |
GO:0035483 |
gastric emptying(GO:0035483) |
| 0.1 |
0.3 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.1 |
0.5 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.2 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.0 |
0.0 |
GO:0060581 |
ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
| 0.0 |
0.3 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.2 |
GO:0046838 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) |
| 0.0 |
1.8 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.0 |
0.1 |
GO:2001055 |
positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
| 0.0 |
0.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.2 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.0 |
0.3 |
GO:0000492 |
box C/D snoRNP assembly(GO:0000492) |
| 0.0 |
1.0 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.7 |
GO:0051450 |
myoblast proliferation(GO:0051450) |
| 0.0 |
0.1 |
GO:0033689 |
negative regulation of osteoblast proliferation(GO:0033689) |
| 0.0 |
0.5 |
GO:0006089 |
lactate metabolic process(GO:0006089) |
| 0.0 |
0.1 |
GO:0034436 |
glycoprotein transport(GO:0034436) |
| 0.0 |
0.3 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.0 |
0.7 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
1.2 |
GO:0007339 |
binding of sperm to zona pellucida(GO:0007339) |
| 0.0 |
0.1 |
GO:0030974 |
thiamine pyrophosphate transport(GO:0030974) |
| 0.0 |
0.5 |
GO:0016558 |
protein import into peroxisome matrix(GO:0016558) |
| 0.0 |
0.2 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.0 |
0.7 |
GO:0034453 |
microtubule anchoring(GO:0034453) |
| 0.0 |
1.2 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.0 |
0.3 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.0 |
1.2 |
GO:1903432 |
regulation of TORC1 signaling(GO:1903432) |
| 0.0 |
0.1 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.0 |
0.2 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.0 |
0.4 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.0 |
0.8 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.2 |
GO:0010992 |
ubiquitin homeostasis(GO:0010992) |
| 0.0 |
0.0 |
GO:0070272 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.0 |
0.7 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.5 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.0 |
1.4 |
GO:0006805 |
xenobiotic metabolic process(GO:0006805) |
| 0.0 |
0.6 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.3 |
GO:0042574 |
retinal metabolic process(GO:0042574) |
| 0.0 |
0.2 |
GO:0070836 |
caveola assembly(GO:0070836) |
| 0.0 |
0.9 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.0 |
0.3 |
GO:0006766 |
vitamin metabolic process(GO:0006766) |
| 0.0 |
0.3 |
GO:1902018 |
negative regulation of cilium assembly(GO:1902018) |
| 0.0 |
1.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.4 |
GO:0006228 |
UTP biosynthetic process(GO:0006228) |
| 0.0 |
0.1 |
GO:0051799 |
negative regulation of hair follicle development(GO:0051799) |
| 0.0 |
0.2 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.0 |
4.7 |
GO:0006457 |
protein folding(GO:0006457) |
| 0.0 |
0.0 |
GO:1990918 |
double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 |
0.0 |
GO:0014722 |
regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
| 0.0 |
0.4 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.2 |
GO:0070934 |
CRD-mediated mRNA stabilization(GO:0070934) |
| 0.0 |
0.5 |
GO:0015813 |
L-glutamate transport(GO:0015813) |
| 0.0 |
0.2 |
GO:0001712 |
ectodermal cell fate commitment(GO:0001712) |
| 0.0 |
1.4 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.2 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.0 |
0.1 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.3 |
GO:0010575 |
positive regulation of vascular endothelial growth factor production(GO:0010575) |
| 0.0 |
0.0 |
GO:0038001 |
paracrine signaling(GO:0038001) |
| 0.0 |
0.2 |
GO:0060050 |
positive regulation of protein glycosylation(GO:0060050) |
| 0.0 |
1.5 |
GO:0006506 |
GPI anchor biosynthetic process(GO:0006506) |
| 0.0 |
0.2 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.0 |
0.4 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.1 |
GO:0002304 |
gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.0 |
1.1 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.5 |
GO:0045475 |
locomotor rhythm(GO:0045475) |
| 0.0 |
0.1 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.0 |
0.1 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.0 |
0.4 |
GO:1902895 |
positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
| 0.0 |
0.1 |
GO:0046501 |
protoporphyrinogen IX metabolic process(GO:0046501) |
| 0.0 |
0.0 |
GO:0009957 |
epidermal cell fate specification(GO:0009957) |
| 0.0 |
0.0 |
GO:1901858 |
regulation of mitochondrial DNA metabolic process(GO:1901858) |
| 0.0 |
2.1 |
GO:0006413 |
translational initiation(GO:0006413) |
| 0.0 |
0.2 |
GO:2000210 |
positive regulation of anoikis(GO:2000210) |
| 0.0 |
0.1 |
GO:0070164 |
adiponectin secretion(GO:0070162) regulation of adiponectin secretion(GO:0070163) negative regulation of adiponectin secretion(GO:0070164) |
| 0.0 |
0.1 |
GO:0021979 |
hypothalamus cell differentiation(GO:0021979) |
| 0.0 |
0.2 |
GO:0000707 |
meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 |
0.8 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.2 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.2 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.0 |
1.7 |
GO:0006892 |
post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.0 |
0.3 |
GO:0032825 |
positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.0 |
0.1 |
GO:0046015 |
regulation of transcription by glucose(GO:0046015) |
| 0.0 |
0.4 |
GO:0003334 |
keratinocyte development(GO:0003334) |
| 0.0 |
0.3 |
GO:0000083 |
regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.0 |
0.2 |
GO:0036260 |
7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.5 |
GO:0016045 |
detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.0 |
0.1 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.0 |
0.2 |
GO:0002076 |
osteoblast development(GO:0002076) |
| 0.0 |
0.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.1 |
GO:0006545 |
glycine biosynthetic process(GO:0006545) |
| 0.0 |
0.2 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.9 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.0 |
0.7 |
GO:1902476 |
chloride transmembrane transport(GO:1902476) |
| 0.0 |
0.2 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 |
0.2 |
GO:0043649 |
dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 |
0.1 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.0 |
0.3 |
GO:0046716 |
muscle cell cellular homeostasis(GO:0046716) |
| 0.0 |
0.1 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.1 |
GO:0042228 |
interleukin-8 biosynthetic process(GO:0042228) regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.0 |
0.2 |
GO:0042635 |
positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.0 |
0.4 |
GO:0014741 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.0 |
0.6 |
GO:1902653 |
cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
| 0.0 |
0.0 |
GO:0048295 |
positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.0 |
0.3 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.0 |
0.1 |
GO:0045086 |
positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
| 0.0 |
0.2 |
GO:0072530 |
purine-containing compound transmembrane transport(GO:0072530) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.1 |
GO:0000706 |
meiotic DNA double-strand break processing(GO:0000706) meiotic DNA double-strand break processing involved in reciprocal meiotic recombination(GO:0010705) |
| 0.0 |
0.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.0 |
0.1 |
GO:1901675 |
response to methylglyoxal(GO:0051595) negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.0 |
0.1 |
GO:1905031 |
regulation of potassium ion export across plasma membrane(GO:1903764) regulation of membrane repolarization during ventricular cardiac muscle cell action potential(GO:1905024) regulation of membrane repolarization during cardiac muscle cell action potential(GO:1905031) |
| 0.0 |
0.1 |
GO:0061744 |
psychomotor behavior(GO:0036343) motor behavior(GO:0061744) |
| 0.0 |
0.2 |
GO:0060124 |
positive regulation of growth hormone secretion(GO:0060124) |
| 0.0 |
0.4 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0034138 |
toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 |
0.6 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
| 0.0 |
0.1 |
GO:0060268 |
negative regulation of respiratory burst(GO:0060268) |
| 0.0 |
0.0 |
GO:0001767 |
establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
| 0.0 |
0.1 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.1 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.4 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.1 |
GO:1903286 |
regulation of potassium ion import(GO:1903286) |
| 0.0 |
0.1 |
GO:0050917 |
sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.2 |
GO:0046498 |
S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.0 |
0.0 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.0 |
0.4 |
GO:0061036 |
positive regulation of cartilage development(GO:0061036) |
| 0.0 |
0.2 |
GO:0051725 |
protein de-ADP-ribosylation(GO:0051725) |
| 0.0 |
0.5 |
GO:1904355 |
positive regulation of telomere capping(GO:1904355) |
| 0.0 |
0.4 |
GO:0006054 |
N-acetylneuraminate metabolic process(GO:0006054) |
| 0.0 |
0.3 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.1 |
GO:0072093 |
metanephric renal vesicle formation(GO:0072093) |
| 0.0 |
0.0 |
GO:0060382 |
regulation of DNA strand elongation(GO:0060382) |
| 0.0 |
0.4 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.0 |
0.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.0 |
0.0 |
GO:2000676 |
positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.0 |
0.3 |
GO:0001886 |
endothelial cell morphogenesis(GO:0001886) |
| 0.0 |
0.1 |
GO:0034331 |
cell junction maintenance(GO:0034331) cell-cell junction maintenance(GO:0045217) |
| 0.0 |
0.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.2 |
GO:0006474 |
N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 |
0.1 |
GO:0007512 |
adult heart development(GO:0007512) |
| 0.0 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.2 |
GO:0002862 |
negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
| 0.0 |
0.1 |
GO:0030201 |
heparan sulfate proteoglycan metabolic process(GO:0030201) |
| 0.0 |
0.1 |
GO:0000097 |
sulfur amino acid biosynthetic process(GO:0000097) |
| 0.0 |
0.1 |
GO:0061386 |
closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.0 |
0.1 |
GO:0045060 |
negative thymic T cell selection(GO:0045060) |
| 0.0 |
0.1 |
GO:0060717 |
chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
| 0.0 |
0.1 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.0 |
0.1 |
GO:0033194 |
response to hydroperoxide(GO:0033194) |
| 0.0 |
0.1 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 |
0.1 |
GO:0036462 |
TRAIL-activated apoptotic signaling pathway(GO:0036462) |
| 0.0 |
0.3 |
GO:0046597 |
negative regulation of viral entry into host cell(GO:0046597) |
| 0.0 |
0.6 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.0 |
0.3 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.2 |
GO:0032515 |
negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 |
0.1 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.0 |
0.2 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
1.4 |
GO:0008033 |
tRNA processing(GO:0008033) |
| 0.0 |
0.0 |
GO:0043504 |
mitochondrial DNA repair(GO:0043504) |
| 0.0 |
0.3 |
GO:0048305 |
immunoglobulin secretion(GO:0048305) |
| 0.0 |
0.3 |
GO:0050927 |
positive regulation of positive chemotaxis(GO:0050927) |
| 0.0 |
0.2 |
GO:1900383 |
regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.0 |
0.1 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.0 |
0.0 |
GO:0033693 |
neurofilament bundle assembly(GO:0033693) |
| 0.0 |
0.5 |
GO:0045494 |
photoreceptor cell maintenance(GO:0045494) |
| 0.0 |
0.3 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.1 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.0 |
0.3 |
GO:0060612 |
adipose tissue development(GO:0060612) |
| 0.0 |
0.2 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.0 |
GO:0072525 |
pyridine-containing compound biosynthetic process(GO:0072525) |
| 0.0 |
0.1 |
GO:0019884 |
antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.3 |
GO:0019373 |
epoxygenase P450 pathway(GO:0019373) |
| 0.0 |
0.2 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.1 |
GO:0021767 |
mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) positive regulation of lens fiber cell differentiation(GO:1902748) |
| 0.0 |
0.1 |
GO:1902031 |
regulation of NADP metabolic process(GO:1902031) |
| 0.0 |
0.0 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.0 |
0.1 |
GO:0070269 |
pyroptosis(GO:0070269) |
| 0.0 |
0.0 |
GO:0034030 |
nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.0 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.0 |
0.1 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 |
0.0 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.0 |
0.1 |
GO:0031643 |
positive regulation of myelination(GO:0031643) |
| 0.0 |
0.3 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.0 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.0 |
0.2 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.0 |
0.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.0 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.1 |
GO:0002829 |
negative regulation of type 2 immune response(GO:0002829) |
